For the year ending 2025-12-31, INVA had $245,977K increase in cash & cash equivalents over the period. $195,799K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net income | 271,165 |
| Deferred income taxes | 43,847 |
| Amortization of capitalized fees and depreciation of property and equipment | 13,951 |
| Amortization of acquired intangible assets | 26,277 |
| Inventory fair value step-up adjustment included in cost of products sold | 4,841 |
| Stock-based compensation | 9,452 |
| Amortization of debt discount and issuance costs | 1,887 |
| Changes in fair values of equity method investments, net | 141,433 |
| Changes in fair values of equity and long-term investments, net | 20,160 |
| Acquired in-process research and development assets | 9,368 |
| Other non-cash items | -1,897 |
| Accounts receivable | 14,574 |
| Receivables from collaboration arrangements | -7,623 |
| Inventory | 12,919 |
| Prepaid expenses | 5,658 |
| Other assets | 1,078 |
| Accounts payable | 2,834 |
| Accrued personnel-related expenses and other accrued liabilities | -5,790 |
| Accrued interest payable | -1,804 |
| Deferred revenue | 3,144 |
| Income tax payable | 4,060 |
| Net cash provided by operating activities | 196,930 |
| Acquisition of intangible asset | 0 |
| Purchases of trading securities | 60,899 |
| Proceeds from trading securities | 8,427 |
| Purchases of equity and long-term investments | 17,500 |
| Purchases of equity investments managed by isp fund lp | 0 |
| Sales of equity investments managed by isp fund lp | 28,164 |
| Purchases and sales of other investments managed by isp fund lp, net | -92,791 |
| Cash paid for in-process research and development assets acquired | 9,368 |
| Purchases of property and equipment | 1,131 |
| Sale of property and equipment | 12 |
| Net cash provided by (used in) investing activities | 40,496 |
| Repurchase of common stock | 4,532 |
| Repurchase of shares to satisfy tax withholding | 143 |
| Proceeds from issuances of common stock, net | 2,553 |
| Proceeds from exercise of warrants | 10,698 |
| Payment for repurchase of convertible notes-Convertible Subordinated Notes2023 | 0 |
| Payment for repurchase of convertible notes-Convertible Senior Notes2025 | 25 |
| Net cash provided by (used in) financing activities | 8,551 |
| Net increase (decrease) in cash and cash equivalents | 245,977 |
| Cash and cash equivalents at beginning of period | 304,964 |
| Cash and cash equivalents at end of period | 550,941 |
Innoviva, Inc. (INVA)
Innoviva, Inc. (INVA)